The eCoin system, accepted by the united state Food and Drug Administration in March 2022 for the therapy of seriousness urinary system incontinence, is based on tibial nerve excitement. The tibial nerve is involved in motion and sensation in the legs and feet, and it additionally affects the nerves that control the bladder.